Toll-like Receptor 9-mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 2003 Aug 6

PMID 12900525

Citations 456

Authors

Jennifer Lund

Ayuko Sato

Shizuo Akira

Ruslan Medzhitov

Akiko Iwasaki

Affiliations

Soon will be listed here.

Abstract

Plasmacytoid dendritic cells (pDCs) have been identified as a potent secretor of the type I interferons (IFNs) in response to CpG as well as several viruses. In this study, we examined the molecular mechanism of virus recognition by pDCs. First, we demonstrated that the CD11c+Gr-1intB220+ pDCs from mouse bone marrow secreted high levels of IFN-alpha in response to either live or UV-inactivated Herpes simplex virus-2 (HSV-2). Next, we identified that IFN-alpha secretion by pDCs required the expression of the adaptor molecule MyD88, suggesting the involvement of a Toll-like receptor (TLR) in HSV-2 recognition. To test whether a TLR mediates HSV-2-induced IFN-alpha secretion from pDCs, various knockout mice were examined. These experiments revealed a clear requirement for TLR9 in this process. Further, we demonstrated that purified HSV-2 DNA can trigger IFN-alpha secretion from pDCs and that inhibitory CpG oligonucleotide treatment diminished HSV-induced IFN-alpha secretion by pDCs in a dose-dependent manner. The recognition of HSV-2 by TLR9 was mediated through an endocytic pathway that was inhibited by chloroquine or bafilomycin A1. The strict requirement for TLR9 in IFN-alpha secretion was further confirmed by the inoculation of HSV-2 in vivo. Therefore, these results demonstrate a novel mechanism whereby the genomic DNA of a virus can engage TLR9 and result in the secretion of IFN-alpha by pDCs.

Citing Articles

Innate Immune Cell Functions Contribute to Spontaneous HIV Control.

Huber A, Baas F, van der Ven A, Dos Santos J Curr HIV/AIDS Rep. 2024; 22(1):6.

PMID: 39614998 PMC: 11608392. DOI: 10.1007/s11904-024-00713-0.

TRIM Proteins: Key Regulators of Immunity to Herpesvirus Infection.

Sayyad Z, Acharya D, Gack M Viruses. 2024; 16(11).

PMID: 39599852 PMC: 11599090. DOI: 10.3390/v16111738.

Safety, pharmacokinetics, biomarker response and efficacy of E6742: a dual antagonist of Toll-like receptors 7 and 8, in a first in patient, randomised, double-blind, phase I/II study in systemic lupus erythematosus.

Tanaka Y, Kumanogoh A, Atsumi T, Ishii T, Tago F, Aoki M RMD Open. 2024; 10(3).

PMID: 39289029 PMC: 11409405. DOI: 10.1136/rmdopen-2024-004701.

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives.

Hu D, Sheeja Prabhakaran H, Zhang Y, Luo G, He W, Liou Y Crit Care. 2024; 28(1):292.

PMID: 39227925 PMC: 11373266. DOI: 10.1186/s13054-024-05069-w.

Vaccine adjuvants for infectious disease in the clinic.

Goetz M, Thotathil N, Zhao Z, Mitragotri S Bioeng Transl Med. 2024; 9(4):e10663.

PMID: 39036089 PMC: 11256182. DOI: 10.1002/btm2.10663.

References

Zheng M, Klinman D, Gierynska M, Rouse B . DNA containing CpG motifs induces angiogenesis. Proc Natl Acad Sci U S A. 2002; 99(13):8944-9. PMC: 124403. DOI: 10.1073/pnas.132605599. View

Sieczkarski S, Whittaker G . Dissecting virus entry via endocytosis. J Gen Virol. 2002; 83(Pt 7):1535-1545. DOI: 10.1099/0022-1317-83-7-1535. View

Katze M, He Y, Gale Jr M . Viruses and interferon: a fight for supremacy. Nat Rev Immunol. 2002; 2(9):675-87. DOI: 10.1038/nri888. View

OKeeffe M, Hochrein H, Vremec D, Caminschi I, Miller J, Anders E . Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus. J Exp Med. 2002; 196(10):1307-19. PMC: 2193989. DOI: 10.1084/jem.20021031. View

Gibson S, Lindh J, Riter T, Gleason R, Rogers L, Fuller A . Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. Cell Immunol. 2002; 218(1-2):74-86. DOI: 10.1016/s0008-8749(02)00517-8. View

Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K . Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol. 2002; 169(12):6668-72. DOI: 10.4049/jimmunol.169.12.6668. View

Brawand P, Fitzpatrick D, Greenfield B, Brasel K, Maliszewski C, De Smedt T . Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs. J Immunol. 2002; 169(12):6711-9. DOI: 10.4049/jimmunol.169.12.6711. View

Boonstra A, Asselin-Paturel C, Gilliet M, Crain C, Trinchieri G, Liu Y . Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J Exp Med. 2003; 197(1):101-9. PMC: 2193804. DOI: 10.1084/jem.20021908. View

Zhao X, Deak E, Soderberg K, Linehan M, Spezzano D, Zhu J . Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med. 2003; 197(2):153-62. PMC: 2193810. DOI: 10.1084/jem.20021109. View

10.

Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T . TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol. 2003; 4(2):161-7. DOI: 10.1038/ni886. View

11.

Karlin S, DOERFLER W, Cardon L . Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses?. J Virol. 1994; 68(5):2889-97. PMC: 236777. DOI: 10.1128/JVI.68.5.2889-2897.1994. View

12.

Muller U, Steinhoff U, Reis L, Hemmi S, Pavlovic J, Zinkernagel R . Functional role of type I and type II interferons in antiviral defense. Science. 1994; 264(5167):1918-21. DOI: 10.1126/science.8009221. View

13.

Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M . Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 1998; 9(1):143-50. DOI: 10.1016/s1074-7613(00)80596-8. View

14.

Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y . Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol. 1999; 162(7):3749-52. View

15.

Eloranta M, Alm G . Splenic marginal metallophilic macrophages and marginal zone macrophages are the major interferon-alpha/beta producers in mice upon intravenous challenge with herpes simplex virus. Scand J Immunol. 1999; 49(4):391-4. DOI: 10.1046/j.1365-3083.1999.00514.x. View

16.

Cates Jr W . Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis. 1999; 26(4 Suppl):S2-7. DOI: 10.1097/00007435-199904001-00002. View

17.

Siegal F, Kadowaki N, Shodell M, Shah K, Ho S, Antonenko S . The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999; 284(5421):1835-7. DOI: 10.1126/science.284.5421.1835. View

18.

Jones C, Taylor T, Knipe D . Biological properties of herpes simplex virus 2 replication-defective mutant strains in a murine nasal infection model. Virology. 2000; 278(1):137-50. DOI: 10.1006/viro.2000.0628. View

19.

Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H . A Toll-like receptor recognizes bacterial DNA. Nature. 2000; 408(6813):740-5. DOI: 10.1038/35047123. View

20.

Horng T, BARTON G, Medzhitov R . TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol. 2001; 2(9):835-41. DOI: 10.1038/ni0901-835. View